Market Overview:
The global rheumatic fever treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of rheumatic fever, rising awareness about available treatments, and growing demand for better healthcare facilities. The global rheumatic fever treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibiotics, anti-inflammatory medication, anticonvulsant medication, and others. Antibiotics are expected to account for a major share of this market owing to their high usage in treating rheumatic fever. On the basis of application, hospitals are expected to account for a major share of this market owing to their large patient base and availability of advanced diagnostic and treatment facilities. Clinics are also anticipated to witness significant growth during the forecast period due with rising demand for outpatient care services across regions.
Product Definition:
Rheumatic fever treatment is the use of antibiotics to treat strep throat, a common cause of rheumatic fever. Rheumatic fever is a serious complication of strep throat that can damage the heart, joints, and other organs. Treatment with antibiotics helps reduce the risk of developing rheumatic fever.
Antibiotics:
Antibiotics Market Size, Share & Trends Analysis Report By Product (Penicillin, Cephalosporin), By Application (Rheumatic Fever Treatment), And Segment Forecasts, 2019 - 2026 -> The global antibiotics market size was valued at USD 21.8 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 3.0% from 2019 to 2026.
Anti-Inflammatory Medication:
Anti-inflammatory medication is used to reduce the swelling, redness, and pain caused by inflammation. The most common types of medications used for inflammatory conditions are nonsteroidal anti-inflammatory drugs (NSAIDs) and steroids.
Application Insights:
Based on application, the global market is segmented into hospitals, clinics and diagnostic centers, and others. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities at a global level. Moreover, presence of highly skilled medical staff with experience in handling rheumatic fever patients will also propel growth over the forecast period.
The majority of patients suffering from Rheumatoid arthritis or OA are referred to a hospital for diagnosis and treatment due to increased awareness about early diagnosis among general public as well as healthcare professionals.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure and high awareness levels regarding early diagnosis are some factors responsible for its large share. Moreover, rising prevalence of rheumatic diseases is anticipated to fuel the demand for therapeutics in this region during the forecast period.
Asia Pacific is expected to witness lucrative growth over the coming years owing to improving healthcare facilities and growing target population in countries such as India, China, Japan, Malaysia & Singapore. In addition, increasing medical tourism due to affordable treatment options will also boost regional growth during the forecast period.
Growth Factors:
- Increasing incidence of rheumatic fever
- Growing awareness about the disease and its treatment options
- Rising demand for better and more effective therapies for rheumatic fever
- Technological advancements in the field of rheumatic fever treatment
- Growing number of research studies on rheumatic fever
Scope Of The Report
Report Attributes
Report Details
Report Title
Rheumatic Fever Treatment Market Research Report
By Type
Antibiotics, Anti-Inflammatory Medication, Anticonvulsant Medication, Others
By Application
Hospitals, Clinics, Diagnostic Centers, Others
By Companies
Pfizer, Abbott Laboratories, Johnson & Johnson, Roche, Novartis, Bristol-Myers Squibb, Eli Lily, AstraZeneca, Bayer, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
123
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Rheumatic Fever Treatment Market Report Segments:
The global Rheumatic Fever Treatment market is segmented on the basis of:
Types
Antibiotics, Anti-Inflammatory Medication, Anticonvulsant Medication, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Abbott Laboratories
- Johnson & Johnson
- Roche
- Novartis
- Bristol-Myers Squibb
- Eli Lily
- AstraZeneca
- Bayer
- Bausch Health
Highlights of The Rheumatic Fever Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Anti-Inflammatory Medication
- Anticonvulsant Medication
- Others
- By Application:
- Hospitals
- Clinics
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rheumatic Fever Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rheumatic fever is a serious illness caused by the Epstein-Barr virus. It can cause joint pain, swelling, and stiffness in the joints. Treatment usually includes antibiotics to fight the infection and pain relief medications. In some cases, surgery may be needed to remove fluid from around the joints.
Some of the major players in the rheumatic fever treatment market are Pfizer, Abbott Laboratories, Johnson & Johnson, Roche, Novartis, Bristol-Myers Squibb, Eli Lily, AstraZeneca, Bayer, Bausch Health.
The rheumatic fever treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rheumatic Fever Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rheumatic Fever Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rheumatic Fever Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rheumatic Fever Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rheumatic Fever Treatment Market Size & Forecast, 2020-2028
4.5.1 Rheumatic Fever Treatment Market Size and Y-o-Y Growth
4.5.2 Rheumatic Fever Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Anti-Inflammatory Medication
5.2.3 Anticonvulsant Medication
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centers
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rheumatic Fever Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rheumatic Fever Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Anti-Inflammatory Medication
9.6.3 Anticonvulsant Medication
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centers
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Anti-Inflammatory Medication
10.6.3 Anticonvulsant Medication
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centers
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Anti-Inflammatory Medication
11.6.3 Anticonvulsant Medication
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centers
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Anti-Inflammatory Medication
12.6.3 Anticonvulsant Medication
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centers
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Anti-Inflammatory Medication
13.6.3 Anticonvulsant Medication
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centers
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rheumatic Fever Treatment Market: Competitive Dashboard
14.2 Global Rheumatic Fever Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Abbott Laboratories
14.3.3 Johnson & Johnson
14.3.4 Roche
14.3.5 Novartis
14.3.6 Bristol-Myers Squibb
14.3.7 Eli Lily
14.3.8 AstraZeneca
14.3.9 Bayer
14.3.10 Bausch Health
